Temasek Participates in Series B Round in Homology Medicines

Posted on 08/03/2017


Sovereign wealth capital keeps on targeting gene editing companies. Gene editing could have major implications on global health. China has been very aggressive in the field of gene editing in recent years. Bedford, Massachusetts-based Homology Medicines Inc., a genetic medicines company translating proprietary gene editing and gene therapy technologies for many uses, raised US$ 83.5 […]